Loading…

Analysis of Gene Expression in the Tumor-Associated Macrophage

Introduction The tumor-associated macrophage (TAM) is at the front line of the host’s defense against malignancy and provides an attractive target for immune-modulatory therapy. However, factors present within the tumor microenvironment can alter macrophage phenotype, preventing its cytotoxic activi...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of surgical research 2007-09, Vol.142 (1), p.119-128
Main Authors: Duff, Michael D., M.Ch. A.F.R.C.S.I, Mestre, Juan, M.D, Maddali, Sirish, M.D, Yan, Zhao Ping, M.D, Stapleton, Philip, M.D., Ph.D, Daly, John M., M.D
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction The tumor-associated macrophage (TAM) is at the front line of the host’s defense against malignancy and provides an attractive target for immune-modulatory therapy. However, factors present within the tumor microenvironment can alter macrophage phenotype, preventing its cytotoxic activity and reducing its susceptibility to interferon-γ and lipopolysaccharide-mediated stimulation. Methods Macrophages were isolated from subcutaneous B16 melanoma tumors implanted in C57 BL/6 mice. Wound macrophages were harvested from subcutaneously-implanted PVA sponges, and resting peritoneal macrophages were harvested by peritoneal lavage. Gene expression was analyzed using an Atlas cDNA array (Clontech, Mountain View, CA). Results TAM demonstrated a pattern of gene expression distinct from both wound and peritoneal macrophage. There is an increase in proliferation-associated genes and in genes encoding the ultrastructural proteins cofillin, zyxin, and vimentin more commonly associated with fibroblast-like cells. In addition, an observed decrease in expression of the CD14 gene, and increase in inhibitory pathways including osteopontin and its receptor CD44, the inositol 1,4,5-triphosphate receptor, and the receptors for interleukin-4 and granulocyte monocyte-colony stimulating factor could explain the resistance of TAM to lipopolysaccharide-mediated stimulation. There was also a significant decrease in the expression of the interferon-γ second messenger, IRF-1. Conclusions This study has identified a number of pathways involved in the suppression of TAM function. Targeting of these pathways may allow for the generation of more effective immune-modulatory anti-neoplastic therapy.
ISSN:0022-4804
1095-8673
DOI:10.1016/j.jss.2006.12.542